Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 1, 2006, Pages 54-59

  Lettesjö, Helene ^a   Hansson, Tony ^a,b   Peterson, Christer ^a   Ung, Kjell Arne ^c   Ringström, Gisela ^d   Abrahamsson, Hasse ^d   Simrén, Magnus ^d  

^a Thermo Fisher Scientific   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Skövde Hospital   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Collagenous colitis; Cytokine; Faeces; Inflammation; Inflammatory bowel disease; Irritable bowel syndrome; Stool

Indexed keywords

BIOLOGICAL MARKER; EOSINOPHIL PROTEIN X; INTERLEUKIN 1BETA; MYELOPEROXIDASE; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; COLLAGENOUS COLITIS; CONTROLLED STUDY; DISEASE MARKER; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERNATANT;

ADULT; AGED; BIOLOGICAL MARKERS; COLITIS, COLLAGENOUS; DIAGNOSIS, DIFFERENTIAL; EOSINOPHIL-DERIVED NEUROTOXIN; FECES; FEMALE; HUMANS; IMMUNOASSAY; INFLAMMATION; INTERLEUKIN-1; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PEROXIDASE; SERINE ENDOPEPTIDASES; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 29744437678     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520510023909     Document Type: Article

References (31)

1. Bradesi S, McRoberts JA, Anton PA, Mayer EA. Inflammatory bowel disease and irritable bowel syndrome: separate or unified? Curr Opin Gastroenterol 2003;19:336-42.
2. Lindström CG. "Collagenous colitis" with watery diarrhea: a new entity? Pathol Eur 1976;11:87-9.
3. Bohr J. A review of collagenous colitis. Scand J Gastroenterol 1998;33:2-9.
4. Offner FA, Jao RV, Lewin KJ, Havelec L, Weinstein WM. Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol 1999;30:451-7.
5. Nishida Y, Murase K, Isomoto H, Furusu H, Mizuta Y, Riddell RH, et al. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology 2002;49:678-82.
6. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 11:1143-117.
7. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of subgroups of functional gastrointestinal disorders. Gastroenterology Intl 1990;3:159-72.
8. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
9. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-57.
10. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
11. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-83.
12. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
13. Peterson CG, Eklund E, Taha Y, Raab Y, Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 2002;97:1755-62.
14. Saiki T, Mitsuyama K, Toyonaga A, Ishida H, Tanikawa K. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:616-22.
15. Robinson DS, Kay AB, Wardlaw AJ. Eosinophils. Clin Allergy Immunol 2002;16:43-75.
16. Levy AM, Yamazaki K, Van Keulen VP, Burgart LJ, Sandborn WJ, Phillips SF, et al. Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis. Am J Gastroenterol 2001;96:1522-8.
17. Venge P. Eosinophil and neutrophil granulocytes. Allergy 1993;48 Suppl 17:39-47; discussion 8-9.
18. Magnusson J, Gellerstedt M, Ahlstedt S, Andersson B, Bengtsson U, Telemo E, et al. A kinetic study in adults with food hypersensitivity assessed as eosinophil activation in fecal samples. Clin Exp Allergy 2003;33:1052-9.
19. Bischoff SC, Mayer J, Wedemeyer J, Meier PN, Zeck-Kapp G, Wedi B, et al. Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut 1997;40:745-53.
20. Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099-104.
21. Jones VA, McLaughlan P, Shorthouse M, Workman E, Hunter JO. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982;2(8308):1115-7.
22. Bischoff SC, Herrmann A, Manns MP. Prevalence of adverse reactions to food in patients with gastrointestinal disease. Allergy 1996;51:811-8.
23. Kristjansson G, Venge P, Wanders A, Lööf L, Hällgren R. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004;53:1806-12.
24. Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol 2004;18:641-61.
25. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
26. Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523-6.
27. Gue M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997;9:271-9.
28. Bienenstock J, Tomioka M, Stead R, Ernst P, Jordana M, Gauldie J, et al. Mast cell involvement in various inflammatory processes. Am Rev Respir Dis 1987;135(6 Pt 2):S5-8.
29. Schwab D, Hahn EG, Raithel M. Histamine content and histamine secretion of the colonic mucosa in patients with collagenous colitis. Inflamm Res 2002;51(Suppl 1):S33-4.
30. Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH. Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 1991;143(3 Pt 2):S55-8.
31. Gui XY. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol 1998;13:980-9.